期刊文献+

辛伐他汀通过p38MAPK信号通路诱导BMSCs成骨分化的研究 被引量:10

Simvastatin induces osteogenic differentiation of BMSCs via p38MAPK pathway
下载PDF
导出
摘要 目的观察辛伐他汀(SIM)体外单独给药对大鼠骨髓间充质干细胞(BMSCs)成骨分化的影响。方法取第二代大鼠BMSCs随机分为4组,对照组(CM):完全培养基培养;诱导组(OM):成骨诱导培养基培养;辛伐他汀组(SIM):含终浓度为10-7mol/L的辛伐他汀的完全培养基培养;阻断剂组(SB+SIM):先用p38MAPK通路阻断剂SB203580干预30min后,加入等浓度辛伐他汀。给药4 h后,Western Blot检测p-p38MAPK、p38MAPK蛋白的表达。给药7d后,进行碱性磷酸酶(ALP)染色和比活性测定。给药7、14d后,采用Real-time PCR法检测ALP、Ι型胶原(COLΙ)、骨钙素(OCN)和Runt相关转录因子2(Runx2)m RNA的表达。结果 1Western Blot检测:OM组和SIM组p-p38MAPK表达水平显著高于CM组和SB+SIM组(P<0.05)。2ALP比活性测定:OM组和SIM组显著高于CM组,与相比,SB+SIM组显著低于SIM组(P<0.05)。3ALP染色:OM组和SIM组细胞胞浆内出现棕色颗粒,而SB+SIM组和CM组未见明显阳性染色颗粒。4Real-time PCR检测:在第7d、14d,OM组和SIM组ALP、COLΙ和Runx2 m RNA表达水平均显著高于CM组,SB+SIM组明显低于SIM组(P<0.05);第7d,OM组OCN m RNA表达水平明显高于CM组(P<0.05);在第14d,OM组和SIM组OCN m RNA表达水平高于CM组,SB+SIM组低于SIM组(P<0.05)。结论辛伐他汀可以在缺乏成骨诱导成分的环境下,通过活化p38MAPK信号诱导大鼠BMSCs向成骨细胞分化。 Objective To observe the effect of simvastatin alone on osteogenic differentiation by rat bone marrow mesenchymal stem cells (BMSCs) in vitro. Methods The second passage of rat BMSCs were randomly divided into 4 groups, CM group (complete medium in the culture), OM group (induction medium in the culture), SIM group (addition of 10-7 mol/L simvastatin in medium), and SB + SIM group (intervention with p38MAPK pathway blocker SB203580 for 30 min, and then addition of 10-7 mol/L simvastatin). Protein expressions of p-p38MAPK and p38MAPK were detected using Western blotting after 4h treatment. ALP staining and ALP activity were measured after 7d treatment. ALP, COLI, OCN, and Runx2 mRNA expressions were detected using real-time RT-PCR assay after 7d and 14d treatment. Results 1 ) Western blotting analysis showed that expression of p- p38MAPK level was significantly higher in OM and SIM groups than in CM and SB + SIM groups ( P 〈 0. 05 ). 2) ALP activity was higher in OM group than in SIM group. It was lower in SB + SIM group than in SIM group ( P 〈 0. 05 ). 3 ) ALP positive staining was shown in OM group and the SIM group, but not in SB + SIM group and CM group. 4) Real-time PCR analysis showed that on 7d and 14d, ALP, COLI and Runx2 mRNA expression levels in OM Group and SIM group were higher than those in CM group ( P 〈 0. 05 ). They were significantly lower in SB + SIM group than in SIM group ( P 〈 0.05 ). OCN mRNA expression level was significantly higher in OM Group than in CM group on 7d (P 〈 0. 05 ). It was higher in OM group and SIM groups than in CM group on 14d (P 〈 0. 05). It was lower in SB + SIM group than in SIM group on 14d (P 〈 0. 05 ). Conclusion In the absence of osteogenic induction environment, simvastatin can induce differentiation of BMSCs into osteoblasts via p38MAPK pathway.
出处 《中国骨质疏松杂志》 CAS CSCD 北大核心 2016年第2期125-130,149,共7页 Chinese Journal of Osteoporosis
基金 河北省自然科学基金(H2013209255) 河北省高等学校科学研究计划(QN20131007) 唐山市科科学技术研究与发展指令计划项目(13130281Z) 唐山市老年医学重点实验室资助项目(14140221B)
关键词 辛伐他汀 骨髓间充质干细胞 成骨分化 p38丝裂原活化激酶 Simvastatin Bone marrow mesenchymal stem cells Osteogenic differentiation p38 Mitogen-activated protein kinase
  • 相关文献

参考文献23

  • 1Mundy G, Garrett R, Harris S, et al. Stimulation of bone formation in vitro and in rodents by statins [ J]. Science, 1999, 286 (5446): 1946-1949.
  • 2Maeda T, Matsunuma A, Kawane T, et al. Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-El cells [ J]. Biochem Biophys Res Commun, 2001, 280(3) : 874-877.
  • 3Chen PY, Sun JS, Tsuang YH, et al. Simvastatin promotes osteoblast viability and differentiation viaRas/Smad/ERK/BMP-2 signaling pathway[ J ]. Nutr Res, 2010, 30 (3) : 191-199.
  • 4Kim IS, Jeong BC, Kim OS, et al. Lactone form 3-hydroxy-3- methylglutaryl-coenzyme A reductase inhibitors(statins) stimulate the osteoblastic differentiation of mouse periodontal ligament cells via theERK pathway[J]. J Periodontal Res, 2011, 46(2): 204 -213.
  • 5Qiao LJ, Kang KL, Heo JS. Simvastatin Promotes Osteogenic Differentiation of Mouse Embryonic Stem Cells Via Canonical Wnt/l~-Catenin Signaling[J]. Mol Cells, 2011, 32 (5): 437- 444.
  • 6Zheng YH, Xiong W, Su K, et al. Muhilineage differentiation of human bone marrow mesenchymal stern cells in vitro and in vivo [J]. ExpTher Med. 2013, 5(6): 1576-1580.
  • 7Samsonraj RM, Rai B, Sathiyanathan P, et al. Establishing criteria for human mesenchymal stem cell potency. Stem Cells, 2015, 33(6) :1878-1891.
  • 8Cai X, Yang F, Yan X, et al. Influence of bone marrow-derived mesenchymal stem cells pre-implantation differentiation approach on periodontal regeneration in vivo. J Clin Periodontol, 2015,42 (4) :380-389.
  • 9Li XD, Liu ZY, Chang B, et al. Panax notoginseng saponins promote osteogenie differentiation of bone marrow stromal cells through the ERK and P38 MAPK signaling pathways. Cell Physiol Biochem, 2011, 28(2) : 367-376.
  • 10Fu L, Tang T, Miao Y, et al. Stimulation of osteogenic differentiation and inhibition of adipogenic differentiation in bone marrow stromai cells by alendronate via ERK and JNK activation. Bone, 2008, 43(1): 40-47.

同被引文献124

  • 1郑杰,张柳,姚树生.辛伐他汀促进大鼠骨髓基质细胞的成骨分化[J].中国骨质疏松杂志,2006,12(3):278-282. 被引量:16
  • 2姚树生,张柳,郑杰.辛伐他汀对大鼠骨髓基质细胞成骨分化的影响[J].第四军医大学学报,2006,27(17):1609-1612. 被引量:15
  • 3Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies [ J ]. Tissue Eng, 2001, 7(2) : 211-228.
  • 4Cheng H, Jiang W, Phillips FM, et al. Osteogenie activity of the fourteen types of human bone morphogenetic proteins (BMPs) [ J]. J Bone Joint Surg Am, 2003, 85-A(8) : 1544-1552.
  • 5Knippenberg M, Helder MN, Zandieh Doulabi B, et al. Osteogenesis versus chondrogenesis by BMP-2 and BMP-7 in adipose stem cells [ J ]. Biochem Biophys Res Commun, 2006, 342 ( 3 ) : 902-908.
  • 6A1-Nbaheen M, Vishnubalaji R, Ali D, et al. Human stromal (mesenchymal) stem cells from bone marrow, adipose tissue and skin exhibit differences in molecular phenotype and differentiation potential[J]. Stem Cell Rev, 2013, 9( 1 ) : 32-43.
  • 7Desmyter S, Gouban Y, Benahmed N, et al. The role of bone morphogcnetic protein-7 ( Osteogcnic Protein- 1 ) in the treatment of tibial frac',ure non-unions. An overview of the use in Belgium[ J]. Acta Orthop Belg, 2008, 74(4) : 534-537.
  • 8Bess S, Line BG, Lafage V, et al. Does recombinant human bone morphogenetic protein-2 use in adult spinal deformity increase complications and are complications associated with location of rhBMP-2 use? A prospective, muhicenter study of 279 consecutive patients [ J ]. Spine ( Phila Pa 1976 ), 2014, 39 ( 3 ) : 233- 242.
  • 9Ongaro A, Pellati A, Bagheri L, et al. Characterization of Notch Signaling During Osteogenic Differentiation in Human Osteosarcoma Cell Line MG63 [J]. J Cell Physiol, 2016, doi: 10. 1002/jcp. 25366, [ Epuh ahead of print].
  • 10Rider DA, Dombrowski C, Sawyer AA, et al. Autocrine fibroblast growth factor 2 increases the multipotentiality of human adipose- derived mesenchymal stem cells [ J ]. Stem Cells, 2008, 26 ( 6 ) : 1598-1608.

引证文献10

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部